LWMI
RDY icon

Legacy Wealth Management (Idaho)’s Dr. Reddy's Laboratories RDY Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15
Closed -$208 – 773
2026
Q1 		$208 Hold
15
– – ﹤0.01% 986
2025
Q4 		$211 Hold
15
– – ﹤0.01% 867
2025
Q3 		$210 Hold
15
– – ﹤0.01% 735
2025
Q2 		$226 Hold
15
– – ﹤0.01% 700
2025
Q1 		$198 Hold
15
– – ﹤0.01% 770
2024
Q4 		$209 Sell
15
-60
-80% -$901 ﹤0.01% 715
2024
Q3 		$219 Buy
+75
New +$1.21K ﹤0.01% 664

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Legacy Wealth Management (Idaho)'s RDY Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 15 shares — an estimated $208 sold.

Legacy Wealth Management (Idaho) first reported a position in RDY in Q3 2024 and held it in 7 quarters. The position peaked at $226 in Q2 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 15 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $208.
  • Legacy Wealth Management (Idaho) first reported a position in Dr. Reddy's Laboratories in Q3 2024 and held it in 7 quarters.
  • Legacy Wealth Management (Idaho)'s Dr. Reddy's Laboratories position peaked at $226 in Q2 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.